Target‐Specific Dermatological Adverse Event Reporting With T‐Cell–Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance, 2016–2026 - Saikat Mandal; Manideepa Maji; Arkadeep Dhali (Cancer Medicine, 2026)